Stocks · News reference
Limoneira Posts Downbeat Q3 Results, Joins Cooper Companies, Navan And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. futures rose, while Limoneira fell 8.4% after missing earnings and sales estimates. Resolution Minerals and Cooper led other premarket decliners.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Where Trump’s Portfolio Meets His Power: Nvidia, Palantir, Dell and More
A Benzinga–Unusual Whales analysis finds a recurring overlap between stocks in Trump's accounts and companies he has praised, regulated or positioned for federal business.
Robinhood To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Tuesday
Analysts cut targets for BOOT, MTN, SFIX, WU, NFLX and ROL; raised HOOD and STAA targets. SFIX upgraded to Neutral, NFLX to Buy.
BMO Capital Maintains Market Perform on American Eagle Outfitters, Raises Price Target to $20
BMO Capital analyst Kelly Crago maintains American Eagle Outfitters (NYSE:AEO) with a Market Perform and raises the price target from $18 to $20.
Agios Pharmaceuticals Insider Sold Shares Worth $296,470
An insider at Agios Pharmaceuticals, Inc. sold company shares valued at approximately $296,470, as disclosed in a recent SEC filing.
4 High-Risk Stocks Built for Big Returns
The article highlights four high-risk, high-reward stocks: Agios Pharmaceuticals awaiting FDA approval for mitapivat to treat sickle cell disease; Navitas Semiconductor pivoting toward AI data centers and high-power chips; Joby Aviation developing eVTOL transportation services with autonomous capabilities; and Viking Therapeutics developing obesity drug VK2735 with potential in a multi-billion dollar market. All require patience but offer significant upside if their respective catalysts materialize.